SCHEMBL10126548

SCHEMBL10126548

CSc1nc(Nc2ccc(F)c(C(=O)N3CCCCC3)c2)c(C(N)=O)c(=O)[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.40
PARP1 P09874 3/20 0.40
CNR2 P34972 5/20 0.38
CNR1 P21554 2/20 0.38
TSHR P16473 1/20 0.37
SYK P43405 1/20 0.37
ALDH1A1 P00352 3/20 0.36
HPGD P15428 3/20 0.36
NPSR1 Q6W5P4 3/20 0.36
KDM4E B2RXH2 2/20 0.36
HTT P42858 1/20 0.36
XDH P47989 1/20 0.36
SLC22A12 Q96S37 1/20 0.36
MKNK1 Q9BUB5 1/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
EPHX2 P34913 1/20 0.35
POLB P06746 1/20 0.35
GFER P55789 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10126553 0.91 EPHX2 (0.44) PARP1CNR2CNR1SMN1; SMN2EPHX2
SCHEMBL10126601 0.90 CNR2 (0.40) CNR2CNR1SYKALDH1A1HPGD
SCHEMBL10126584 0.88 JAK2 (0.45) CNR2CNR1SYK
SCHEMBL10126499 0.88 PTK6 (0.45) CNR2CNR1SYKHPGDXDH
SCHEMBL10156470 0.87 PTK6 (0.40) CNR2CNR1TSHRSYKALDH1A1
SCHEMBL16305320 0.86 HPGD (0.49) TSHRSYKALDH1A1HPGDNPSR1
SCHEMBL10126560 0.85 XDH (0.42) SYKXDHSLC22A12GFERRXFP1
SCHEMBL10156479 0.83 XDH (0.41) XDHSLC22A12GFERRXFP1
SCHEMBL10127123 0.83 CAMK1D (0.46) IRAK4TSHRALDH1A1HPGDHTT
SCHEMBL17340270 0.81 IRAK4 (0.40) IRAK4PARP1CNR2CNR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9487491-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2016-11-08 US disclosed
US-9487491-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2016-11-08 US disclosed
US-8969336-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2015-03-03 US disclosed
US-8969336-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2015-03-03 US disclosed
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-12-18 US disclosed
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-12-18 US disclosed
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 IRAK4 403/4885PARP1 1748/4885CNR2 1453/4885
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 IRAK4 403/4885PARP1 1748/4885CNR2 1453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.